Tags

Type your tag names separated by a space and hit enter

Rubeosis iridis: preoperative iris fluorescein angiography and periocular steroids.
Ophthalmology. 1984 Apr; 91(4):321-5.O

Abstract

To study the risk of developing rubeosis iridis following vitrectomy, the use of preoperative iris fluorescein angiography was prospectively investigated on patients with diabetes mellitus, without any clinically detectable iris or angle neovascularization. With increasing severity of fluorescein leakage, the risk of iris neovascularization with or without glaucoma, six months after vitreous surgery, is significantly increased. It was also determined whether postoperative steroid therapy (periocular triamcinolone acetonide and topical prednisolone phosphate) reduces the risk of developing iris neovascularization after vitrectomy. Controlled and treated patient eyes did not differ significantly in the degree of rubeosis. However, neovascular glaucoma statistically occurred more frequently in the nonsteroid group.

Links

Publisher Full Text

Authors

Ehrenberg M
No affiliation info available
McCuen BW
No affiliation info available
Schindler RH
No affiliation info available
Machemer R
No affiliation info available

MeSH

Diabetic RetinopathyDrug Therapy, CombinationFluorescein AngiographyGlaucomaHumansIrisNeovascularization, PathologicOphthalmic SolutionsPostoperative CarePostoperative ComplicationsPrednisoloneTriamcinolone AcetonideVitreous Body

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S.

Language

eng

PubMed ID

6201792

Citation

Ehrenberg, M, et al. "Rubeosis Iridis: Preoperative Iris Fluorescein Angiography and Periocular Steroids." Ophthalmology, vol. 91, no. 4, 1984, pp. 321-5.
Ehrenberg M, McCuen BW, Schindler RH, et al. Rubeosis iridis: preoperative iris fluorescein angiography and periocular steroids. Ophthalmology. 1984;91(4):321-5.
Ehrenberg, M., McCuen, B. W., Schindler, R. H., & Machemer, R. (1984). Rubeosis iridis: preoperative iris fluorescein angiography and periocular steroids. Ophthalmology, 91(4), 321-5.
Ehrenberg M, et al. Rubeosis Iridis: Preoperative Iris Fluorescein Angiography and Periocular Steroids. Ophthalmology. 1984;91(4):321-5. PubMed PMID: 6201792.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Rubeosis iridis: preoperative iris fluorescein angiography and periocular steroids. AU - Ehrenberg,M, AU - McCuen,B W,2nd AU - Schindler,R H, AU - Machemer,R, PY - 1984/4/1/pubmed PY - 1984/4/1/medline PY - 1984/4/1/entrez SP - 321 EP - 5 JF - Ophthalmology JO - Ophthalmology VL - 91 IS - 4 N2 - To study the risk of developing rubeosis iridis following vitrectomy, the use of preoperative iris fluorescein angiography was prospectively investigated on patients with diabetes mellitus, without any clinically detectable iris or angle neovascularization. With increasing severity of fluorescein leakage, the risk of iris neovascularization with or without glaucoma, six months after vitreous surgery, is significantly increased. It was also determined whether postoperative steroid therapy (periocular triamcinolone acetonide and topical prednisolone phosphate) reduces the risk of developing iris neovascularization after vitrectomy. Controlled and treated patient eyes did not differ significantly in the degree of rubeosis. However, neovascular glaucoma statistically occurred more frequently in the nonsteroid group. SN - 0161-6420 UR - https://www.unboundmedicine.com/medline/citation/6201792/Rubeosis_iridis:_preoperative_iris_fluorescein_angiography_and_periocular_steroids_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0161-6420(84)34292-0 DB - PRIME DP - Unbound Medicine ER -